Exicure agrees to sell GPC-100 program assets to GPCRT Inc. for KRW 6.5 billionNov 10PartnershipExicure, Inc.
Eton posts record Q3 revenue, raises 2026 guidance, advances rare disease pipelineNov 5PartnershipEton Pharmaceuticals, Inc.Updated
Eton Pharmaceuticals posts 99% revenue growth, raises 2026 guidance to over $145 millionAug 13Quarterly updateEton Pharmaceuticals, Inc.